<DOC>
	<DOCNO>NCT00829114</DOCNO>
	<brief_summary>Non-randomized , comparative study ( 1:1 allocation ) study interaction nevirapine-containing antiretroviral therapy combine oral contraceptive pill .</brief_summary>
	<brief_title>Interactions Between Antiretrovirals ( ARVs ) Combined Oral Contraceptives ( COCs )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Willing provide inform consent Willing take COCs follow study requirement Has regular menstrual cycle every 2135 day ( take hormonal contraception ) Last menstrual period ( LMP ) &lt; 35 day study entry Has body mass index 1830 Negative urine pregnancy test enrollment Documented HIV1 infection On nevirapinecontaining ART least three month ( ART group ) CD4 cell count great equal 350 ( nonARV group ) Currently sexually active plan stay sexually active next 6 month Medical contraindication COC use Recent pregnancy ( within 3 month ) Has breastfed last 3 month Last pregnancy ectpoic Has sterilize Has follow condition since last pregnancy , since menarche never pregnant : Pelvic Inflammatory disease Diagnosis infertility Has DMPA within 6 month NET injectable within 3 month study entry ( menses since last injection regardless time ) take hormonal therapy besides COCs ( e.g. , combine injectables , progestin implant intrauterine system , progestinonly contraceptive pill , medroxyprogesterone acetate , hormone replacement therapy ) within 30 day study entry Has acute infection opportunistic disease require therapy within 14 day enrollment Has active drug alcohol use , opinion investigator , would interfere adherence study requirement Has take prohibit medication within 30 day study entry Has chronic diarrhea , malabsorption inability maintain adequate oral intake Has condition ( social medical ) opinion investigator would make study participation unsafe complicate data interpretation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>AE</keyword>
	<keyword>AIDS</keyword>
	<keyword>ALT</keyword>
	<keyword>ART</keyword>
	<keyword>AST</keyword>
	<keyword>DCF</keyword>
	<keyword>DMC</keyword>
	<keyword>FDA</keyword>
	<keyword>GCP</keyword>
	<keyword>HB sAg</keyword>
	<keyword>ICH</keyword>
	<keyword>IND</keyword>
	<keyword>IRB</keyword>
	<keyword>IU</keyword>
	<keyword>mg</keyword>
	<keyword>mm3</keyword>
	<keyword>PCR</keyword>
	<keyword>SAE</keyword>
	<keyword>ULN</keyword>
	<keyword>WB</keyword>
	<keyword>COC</keyword>
	<keyword>Combined Oral Contraceptives</keyword>
</DOC>